Skip to main content

Advertisement

Table 5 OS, 30-day, 3-month and 6-month mortality of discussed risk scoring

From: Prognostic assessment for patients with cancer and incidental pulmonary embolism

Score categories OS months (95%CI) Mortality %(n)
30-d (n = 7) 3-m (n = 33) 6-m (n = 68)
Hull5 Risk Score (n = 227)
Low (n = 45) 32(8.1,5 5.9) 0(0) 2.2(1) 4.4(2)
Intermediate (n = 115) 12.6(8.3, 16.9) 0.9(1) 11.3(13) 25.2(29)
High (n = 67) 5.5 (3.9, 7.2) 9.0(6) 28.4(19) 55.2(37)
  p < .001* p = .004** p < .001** p < .001**
RIETE Risk Score (n = 205)
Very low (n = 27) not reached 0(0) 3.7(1) 7.4(2)
Low (n = 123) 15.9 (11.2, 20.6) 2.4(3) 9.8(12) 22.8(28)
Intermediate (n = 53) 5.4 (4.3, 6.5) 5.7(3) 32.1(17) 56.6(30)
High (n = 2) 2.7 (not calc.) 0%(0) 50(1) 50(1)
  p < .001* p = .185** p < .001** p < .001**
RIETE Risk Score (n = 205)
Low(n = 27) not reached 0(0) 3.7(1) 7.4(2)
High (n = 178) 11.2 (7.7, 14.7) 3.4(6) 16.9(30) 33.1(59)
  p < .001* p = .603** p = .087** p = .006**
  1. *log rank (pooled)
  2. **Kendall’s tau-b exact test